These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 19464192

  • 1. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
    Thomas N, Bechet D, Becuwe P, Tirand L, Vanderesse R, Frochot C, Guillemin F, Barberi-Heyob M.
    J Photochem Photobiol B; 2009 Aug 03; 96(2):101-8. PubMed ID: 19464192
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M.
    J Control Release; 2006 Mar 10; 111(1-2):153-64. PubMed ID: 16423422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
    Tirand L, Thomas N, Dodeller M, Dumas D, Frochot C, Maunit B, Guillemin F, Barberi-Heyob M.
    Drug Metab Dispos; 2007 May 10; 35(5):806-13. PubMed ID: 17283031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 10; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
    Hess AP, Schanz A, Baston-Buest DM, Hirchenhain J, Stoff-Khalili MA, Bielfeld P, Kruessel JS.
    J Reprod Immunol; 2009 Jan 10; 79(2):129-36. PubMed ID: 18996601
    [Abstract] [Full Text] [Related]

  • 14. Functionalized silica-based nanoparticles for photodynamic therapy.
    Couleaud P, Bechet D, Vanderesse R, Barberi-Heyob M, Faure AC, Roux S, Tillement O, Porhel S, Guillemin F, Frochot C.
    Nanomedicine (Lond); 2011 Aug 10; 6(6):995-1009. PubMed ID: 21726134
    [Abstract] [Full Text] [Related]

  • 15. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.
    Bechet D, Tirand L, Faivre B, Plénat F, Bonnet C, Bastogne T, Frochot C, Guillemin F, Barberi-Heyob M.
    Pharm Res; 2010 Mar 10; 27(3):468-79. PubMed ID: 20087632
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
    Schneider R, Schmitt F, Frochot C, Fort Y, Lourette N, Guillemin F, Müller JF, Barberi-Heyob M.
    Bioorg Med Chem; 2005 Apr 15; 13(8):2799-808. PubMed ID: 15781391
    [Abstract] [Full Text] [Related]

  • 19. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
    Herringson TP, Altin JG.
    Int J Pharm; 2011 Jun 15; 411(1-2):206-14. PubMed ID: 21443937
    [Abstract] [Full Text] [Related]

  • 20. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.
    Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K, Fujii S.
    Gynecol Oncol; 2007 Jun 15; 105(3):703-11. PubMed ID: 17376520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.